Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx (HEMO)

Price 1.122p on 03-12-2024 at 17:30:01
Change 0.084p 7.81%
Buy 1.198p
Sell 1.122p
Buy / Sell HEMO Shares
Last Trade: Unknown 247,500.00 at 1.16p
Day's Volume: 3,823,463
Last Close: 1.16p
Open: 1.15p
ISIN: GB00BYX3WZ24
Day's Range 1.122p - 1.15p
52wk Range: 0.876p - 6.30p
Market Capitalisation: £16m
VWAP: 1.148678p
Shares in Issue: 1,402m

Recent Trades History Hemogenyx (HEMO)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 247,500 1.16p OTC Trade
17:08:47 - 03-Dec-24
Sell* 1,090 1.122p SI Trade
16:28:47 - 03-Dec-24
Sell* 94,953 1.122p Automatic Execution
16:28:47 - 03-Dec-24
Buy* 598,341 1.1699p Ordinary
16:22:34 - 03-Dec-24
Sell* 105,715 1.1342p Ordinary
16:16:00 - 03-Dec-24
Unknown* 657 1.20p OTC Trade
14:57:32 - 03-Dec-24
Unknown* 4,359 1.122p OTC Trade
14:36:49 - 03-Dec-24
Buy* 3,469 1.1791p Ordinary
15:22:22 - 03-Dec-24
Sell* 29,252 1.1299p Ordinary
15:15:50 - 03-Dec-24
Sell* 15,028 1.1329p Ordinary
15:01:36 - 03-Dec-24

Share Price History for Hemogenyx

Time period:
to
Date Open High Low Close Volume

Share News for Hemogenyx

UK shareholder meetings calendar - next 7 days

2nd Dec 2024 13:32

Read More

IN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trial

30th Oct 2024 11:09

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for blood diseases - Schedules the opening of the first clinical site for the phase 1 clinical trial of Hemo-Car-T, a treatment for relapsed or refractory acute myeloid leukemia in adults, formally called HG-CT-1, for the third week of November. The site will open following clearance from the Institutional Review Board and a site initiation visit. Read More

Hemogenyx Pharmaceuticals loss narrows amid reduced expenses

27th Sep 2024 18:25

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said its pretax loss narrowed in the first half of 2024, following a reduction in expenses. Read More

EARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrows

27th Sep 2024 15:55

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Light Science Technologies wins two new contracts

9th Sep 2024 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,359.41
Change46.52

Login to your account

Forgot Password?

Not Registered